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The noncoding RNA designated as microRNA (miRNA) is a large group of small single-stranded regulatory RNA and has
generated wide-spread interest in human disease studies. To facilitate delineating the role of microRNAs in cancer pathology,
we sought to explore the feasibility of detecting microRNA expression in formalin-ﬁxed paraﬃn-embedded (FFPE) tissues. Using
FFPE materials, we have compared ﬂuorescent in situ hybridization (FISH) procedures to detect miR-146a with (a) diﬀerent
synthetic probes: regular custom DNA oligonucleotides versus locked nucleic acid (LNA) incorporated DNA oligonucleotides; (b)
diﬀerent reporters for the probes: biotin versus digoxigenin (DIG); (c) diﬀerent visualization: traditional versus tyramide signal
ampliﬁcation (TSA) system; (d) diﬀerent blocking reagents for endogenous peroxidase. Finally, we performed miR-146a FISH on
a commercially available oral cancer tissue microarray, which contains 40 cases of oral squamous cell carcinoma (OSCC) and 10
cases of normal epithelia from the human oral cavity. A sample FISH protocol for detecting miR-146a is provided. In summary,
we have established reliable in situ hybridization procedures for detecting the expression of microRNA in FFPE oral cancer tissues.
This method is an important tool for studies on the involvement of microRNA in oral cancer pathology and may have potential
prognostic or diagnostic value.
1.Introduction
MicroRNA refers to the category of single-stranded small
noncoding RNAs that are approximately 22 nucleotides
in length. More than 1500 human microRNA have been
identiﬁed and registered via various approaches including
high throughput screenings (http://www.mirbase.org/). As
more than 30% of human of mRNAs are regulated by
microRNAs, the functional impact of microRNA in physiol-
ogy and pathology has yet to be fully elucidated [1]. Gen-
erally speaking, microRNA imposes its regulatory role by
sequence-speciﬁc but incomplete complementary binding
to its target mRNA sequences, which are usually located
at the 3  untranslated region [1, 2]. This binding may
mediate the degradation of target mRNA or the inhibition
of protein translation eﬃciency of target mRNA. However,
due to the loose stringency of this kind of targeting, the
exact mechanism of speciﬁc microRNA function remains
undeﬁned and is an actively addressed research topic. The
functionandtargetmRNAsofindividualmicroRNAscannot
be reliably predicted via current bioinformatic approaches,
thereby warranting continued experimental interrogation.
The investigation of microRNA expression and its func-
tional relationship with various cancer types has instigated
tremendous interest in employing such molecules as novel
diagnostic or therapeutic modalities in oncology studies
[3, 4]. Recent developments that show correlation between
plasma microRNA levels and cancer have further increased
enthusiasm for this approach due to the easy accessibility of
blood serum and plasma specimens [5]. Similarly abundant
in clinical settings are archived formalin-ﬁxed paraﬃn-
embedded (FFPE) human cancer specimens, which can
provide a rich resource for investigating the relationship
between microRNA expression and cancer progression.2 Journal of Oncology
S t u d i e so ns u c hm a t e r i a lh a v et h ea d d e da d v a n t a g eo f
maintaining the information content from cancer tissue
morphology when in situ hybridization (ISH) is used to
detect microRNA expression [6]. Unlike the frequently used
quantitative reverse transcription polymerase chain reac-
tion (Q-RT-PCR) method, which requires extraction of
RNA, ISH retains the microscopic topological information
content with respect to microRNA expression and makes
it possible to be related to other factors on the same tis-
sue section. However, formalin ﬁxation causes cross-links
between biological molecules, potentially limiting access to
microRNA molecules. Moreover, degradation has been a
constant concern for preservation of RNA molecules in such
tissue samples.
The in situ hybridization technique for nucleic acid de-
tection on tissue and cytological preparations was initi-
ated decades ago [7, 8], when radioisotope labeling and
autoradiography were the only means to visualize positive
hybridization signals. Improvement and development of
newer technologies, such as the advent of nonradioactive
digoxigenin as probe labeling/reporter molecule and the
tyramide signal ampliﬁcation (TSA) system, have made in
situhybridizationmuchmoreaccessible.However,duetothe
short length of microRNA molecules, in situ hybridization
for microRNA detection remains challenging. This paper
demonstrates the feasibility and highlights key technical
factors of developing a protocol for ﬂuorescence in situ
hybridization (FISH) to detect microRNA in archived FFPE
human oral cancer tissues.
2.MaterialsandMethods
2.1. Specimens. Formalin-ﬁxed paraﬃn-embedded tissues
are from lab-archived human oral cancer xenografts (10
blocks) [9] and commercially available human oral cancer
tissue microarray (TMA) sections from US Biomax, Inc.
(Rockville, MD), consisting of 50 tissue cores including
40 oral squamous cell carcinoma and 10 adjacent normal
stratiﬁed squamous epithelia. Xenograft specimen collection
was approved by the Animal Care and Use Committees
(Northwestern University and University of Missouri). Sur-
gically removed xenograft tissues were immediately ﬁxed in
10% neutral buﬀered formalin for 12–24 hours and passed
through dehydration, clearing, and paraﬃn-embedding
steps. Sections were cut at 5μm thick and mounted on
positively charged slides, baked at 65◦Cf o r2h o u r s ,a n d
t h e ns t o r e da tr o o mt e m p e r a t u r ef o rl a t e ru s e .A sf o r
samples which were used to make TMA, according to the
supplier, they were typically put into formalin within 15–
30 minutes after surgical resection. Some of the tissue
samples were snap frozen in liquid nitrogen and stored
there for later ﬁxation. Either way, ﬁxation in neutral
buﬀered formalin was about 24 hours before they were
processed in automatic tissue processor and embedded in
paraﬃn.
2.2. Reagents. Common chemical reagents were purchased
from Sigma Aldrich Co. LLC. (St. Louis, MO, USA) unless
otherwise speciﬁed. Normal goat serum and HRP-conjugat-
ed anti-mouse IgG were from Santa Cruz Biotechnologies,
Inc. (Santa Cruz, CA, USA). Mouse antidigoxigenin and
HRP-conjugated anti-digoxigenin antibodies were obtained
from Roche Applied Science (Indianapolis, IN, USA). TSA-
Cyanine 5 kit (NEL705A) was from Perkin-Elmer (Waltham,
MA,USA),andcontainsHRP-streptavidin,blockingreagent,
ampliﬁcation diluents, and Cyanine 5-conjugated tyramide.
Locked nucleic acid (LNA)-based probes were ordered from
Exiqon, Inc. (Woburn, MA, USA). LNA-based microRNA
miR-146a antisense oligonucleotides were labeled with
digoxigenin(DIG)atthe5  end.ThehumanmiR-146atarget
sequence is UGAGAACUGAAUUCCAUGGGUU, and the
probe sequence is AACCCATGGAATTCAGTTCTCA. The
negative control used scrambled-miR LNA detection probe
that was 5 -DIG labeled. This control probe sequence is
GTGTAACACGTCTATACGCCCA. LNA and non-LNA-
modiﬁed 5  biotinylated miR-146a speciﬁc probe and scram-
bled probe with the same sequences were custom made
from Integrated DNA Technologies, Inc. (Coralville, IA,
USA). ProLong mounting media containing 4 ,6-diamidino-
2-phenylindole (DAPI) was from Invitrogen (Carlsbad, CA,
USA).
2.3. Special Solutions. An important consideration is to use
diethylpyrocarbonate (DEPC)-treated water in all solution
preparation and to exercise caution to maintain a RNase-
free work environment during all procedures. To generate
20x SSC, dissolve the following in 800mL of milli-Q grade
water: 175.3g of NaCl and 88.2g of sodium citrate, adjust
the pH to 7.0 with a few drops of 1M HCl, and adjust
the volume to 1 liter with additional distilled H2O. Sterilize
by autoclaving. To prepare 50x Denhardt’s solution, add
the following to 900mL distilled H2O: 10g Ficoll 400, 10g
polyvinylpyrrolidone, and 10g BSA, then ﬁll up to 1 liter.
Filter the solution prior to storage through a 0.2μMﬁ l t e r
and store at 4◦C( b u tw a r mu pt oa p p r o p r i a t et e m p e r a t u r e
prior to use). The prehybridization solution contains the
following:50%deionizedformamide,2xSSC,1xDenhardt’s,
0.02% SDS, yeast tRNA (0.5mg/mL), and salmon sperm
DNA (0.5mg/mL). The hybridization solution contains 50%
Deionized formamide, 2x SSC, 1x Denhardt’s, 10% dextran
sulfate, yeast tRNA (0.5mg/mL), and salmon sperm DNA
(0.5mg/mL).
2.4. Suppression of Endogenous Peroxidase. For testing the
eﬀectiveness of peroxidase inhibition, two methods (hydro-
gen peroxide versus hydrochloric acid) were tried simultane-
ously. After the sections were dewaxed and rehydrated, two
kinds of fresh prepared solutions: 3% hydrogen peroxide in
phosphate-buﬀered saline (PBS) and 0.024M hydrochloric
acid in ethanol applied, respectively, 200μL per slide, to
two groups of slides and incubated for 10 minutes at
room temperature. Slides were then washed with PBS (2x 5
minutes).TheCyanine5-tyramidestocksolutionwasdiluted
1:50usingtheincluded1Xampliﬁcationdiluenttomakethe
Cyanine5-tyramideworkingsolution.Approximately100μL
of Cyanine 5-tyramide working solution was added per slide,Journal of Oncology 3
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Figure 1: Simpliﬁed scheme of ﬂuorescence in situ hybridization
(FISH) for microRNA detection. Locked nucleic acid (LNA)-
incorporated oligonucleotides with Watson-Crick complimentary
sequence against mature microRNA was used as probe, and the 5 
end of probe was labeled with digoxigenin (DIG). Hybridization
was performed at 50◦C. After successful binding of such probes to
their target sequence, and stringent washing steps to remove excess
and nonspeciﬁcally bound probes, sequentially added were mouse
anti-DIG antibody, horseradish peroxidase (HRP)-conjugated anti-
mouse IgG (or HRP-anti-digoxigenin antibody in place of the 2
antibodies),andtheHRPsubstrateCyanine5-conjugatedtyramide.
Thereafter, the positive signal could be visualized by ﬂuorescence
microscopy with proper ﬁlter sets as described in Materials and
Methods section.
incubated for 10 minutes at room temperature, and washed
(3times,5minuteseach)withPBS.Slideswerethenairdried
in the dark and mounted using ProLong mounting media
with DAPI and coverslips.
2.5. Fluorescence Microscopy. Solidiﬁed ﬂuorescent slides
were observed with the wide ﬁeld function of an Olympus
DSU spinning disc confocal microscope and SlideBook
software version 4.0. Fluorescent ﬁlter sets used for DAPI
are D350/50x and ET455/50m, and for Cy5 are 645/30x
and ET705/72m. Pictures were taken using a Hamamatsu
EMCCD camera.
2.6. Procedures. The typical work ﬂow of our ﬂuorescence
in situ hybridization for miR-146a microRNA detection is
described below. The total procedure can be completed
within 2 days and is adaptable to detecting proteins of
interest at the same time with multicolor labeling. A negative
controlslideshouldalwaysbeincluded thatwillbeotherwise
treated equally but with scrambled probe or without any
probe in the hybridization step. A simpliﬁed scheme is
illustrated in Figure 1.
(1) Deparaﬃnize the Section: Bake the paraﬃns e c t i o n
at 65◦Cf o r1h o u r .D e p a r a ﬃnize in xylene (2x
10 minutes), rehydrate in serial ethanol solutions
(100%, 90%, 80%, 70%), and DEPC-treated water (2
minutes each) and PBS wash (2x 5 minutes).
(2) Pretreatment of the Slide: Cross-linking during ﬁx-
ation can block reagent access to RNA/DNA mol-
ecules, so it is critical to unmask these sites using
proteinases. It is also necessary to block certain
endogenous active molecules that may interfere with
signal development in later steps. To quench endoge-
nous peroxidase: 0.024M HCl in ethanol, incubate
for 10 minutes, then PBS wash (2x 5 minutes).
For proteinase treatment, incubate with Proteinase
K( 2 0 μg/mL, 37◦C for 10 minutes) followed by a
PBS wash (2x 5 minutes), and complete with 4%
paraformaldehyde (PFA) ﬁxation for 10 minutes
followed by a PBS wash for 5 minutes; 100mM
Glycine incubation for 10 minutes; PBS wash (2x 5
minutes) and end with a 2X SSC wash (5 minutes).
(3) Prehybridization: This is meant to block nonspeciﬁc
binding of probes and minimize background signals.
Pre-hybridize for 2 hours at 50◦C in prehybridization
solution, cover with plastic coverslip, and place in a
moist chamber.
(4) Hybridization: Apply speciﬁc and control probes,
respectively. Hybridize overnight (18 hours) at 50◦C
with probe at the concentration of 25nM (1μL
2.5μM DIG labeled probe to 100μL hybridization
solution), cover with plastic coverslip and place in a
moist chamber.
(5) Stringency Wash: This step is critical to remove
nonspeciﬁc probe binding and overloaded probes.
Wash with 2X SSC (37◦Cf o r1 5m i n u t e s )f o l l o w e d
by a high temperature 2X SCC wash (at 50◦Cw i t h
shaking). Next wash with 1X SSC (2x at 37◦Cf o r1 5
minutes),withshakingat50◦Cin1XSCCforanother
15 minutes, and wash with 0.02% SDS in 1X SSC (2x
at 37◦C for 15 minutes), with shaking at 50◦C in the
same buﬀer for another 15 minutes. Then followed
by PBS-T (PBS containing 0.1% tween-20) washes at
room temperature (RT) (4x 5 minutes).
(6) Posthybridization Immunohistochemistry: Use pro-
perly labeled antibody to visualize the positive hy-
bridization signals. Serum block uses 10% normal
goat serum in PBS for 1 hour at room temperature,
followed by mouse anti-DIG (1:250) in the above
blocking solution for 0.5 hour at room temperature;
rinse with PBS-T wash (4x 5 minutes). Add HRP-
conjugated goat anti-mouse IgG (1:500) for 0.5–
1 hour at room temperature. Note that the use of
2 antibodies (mouse anti-DIG and HRP-conjugated
goat anti-mouse IgG) could be replaced with HRP-
conjugated anti-DIG only. Following antibody incu-
bation, wash with PBS-T (4x 5 minutes) and add
Cy5-tyramide working solution (100μL per slide);
incubate at room temperature for 10 minutes. PBS-
T wash (4x 5 minutes); PBS wash (5 minutes), air-
dry for 10 minutes in the dark, and apply ProLong
Gold mounting medium with DAPI and a coverslip.
After overnight solidiﬁcation, slides are ready for
observation with ﬂuorescent microscopy.
3. Results and Discussion
The need to further evaluate the expression and function
of speciﬁc microRNAs in cancer pathology prompted us4 Journal of Oncology
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Figure 2: Suppressing endogenous peroxidase is critical for TSA-based in situ hybridization. Residual peroxidase activity from endogenous
sourcesleadstobackgroundstainingandobscuresthetrulypositivesignals.Hydrogenperoxide(H2O2)andhydrochloricacid(HCl)solution
were compared for eﬀectiveness in suppression of endogenous peroxidase activity. (a, b) Incubation with high concentration (3%) H2O2 in
PBS (instead of more commonly used 0.3% H2O2) for 10 minutes does not suppress endogenous peroxidase. (c, d) The suppression from
0.024M hydrochloric acid in ethanol for 10 minutes is more extensive. Red: Cy5-tyramide showing existence of peroxidase activity, blue:
4 ,6-diamidino-2-phenylindole (DAPI) stained nuclei. Original magniﬁcation 200x.
to establish a method of detecting microRNAs in archived
FFPE materials. Abundant concerns regarding the integrity
of RNA in FFPE samples have been conﬁrmed by studies
showingthatmRNAinFFPEmaterialshasvariousdegreesof
degradation as well as chemical modiﬁcation by the ﬁxative,
rendering downstream analysis of extracted RNA diﬃcult
[10]. Interestingly however, recent studies using microarray
analyses to compare RNA species between paired FFPE and
freshfrozensamplesdemonstratedcloselyrelatedmicroRNA
proﬁles, while mRNA proﬁles exhibited signs of degradation
in FFPE materials [11, 12].Time to ﬁxation, nuclease activity
before ﬁxation, chemical modiﬁcation by formalin and
variation in sample-processing procedures likely contribute
to the decline in mRNA quality in FFPE relative to fresh
frozen tissue samples. However, as demonstrated in the
aforementioned studies, the small size of microRNA as
well as its close association with large protein complexes
enable the relatively better maintenance of their integrity
after formalin ﬁxation and paraﬃn embedding. This high
degree of correlation between microRNA signatures in FFPE
and fresh frozen specimens encourages further exploration
of microRNA detection methods on archived pathology
samples. After optimizing certain critical conditions, we
have found that LNA-based probes labeled with digoxigenin
and combined with TSA ampliﬁcation provided satisfactory
results for miR-146a FISH detection in archived oral cancer
tissues. These results and conditions are discussed below.
Specimen processing in our study was relatively well con-
trolled; we have to acknowledge that results on specimens
from real-life clinical archives may exhibit greater variability.
3.1. Endogenous Peroxidase Is Better Inhibited by Hydrochloric
Acid Solution. Nonradioactive in situ hybridization tech-
niques often rely on immunohistochemistry to amplify pos-
itive hybridization signals. Horseradish peroxidase (HRP)Journal of Oncology 5
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Figure 3: Endogenous biotin in oral cancer tissues. Following satisfactory inhibition of endogenous peroxidase using dilute hydrochloric
acid solution (Figure 2), ﬂuorescence in situ hybridization was performed using (a) 5  biotinylated complementary DNA oligonucleotide
probe against miR-146a or (b) control sample treated the same way but without the addition of probe (i.e., without any exogenous biotin).
The control sample reveals endogenous biotin in oral cancer tissues. Detection used streptavidin-HRP and Cyanine 5-conjugated tyramide.
Red: Cy5-tyramide showing existence of streptavidin-binding activity, blue: DAPI stained nuclei. Original magniﬁcation 200x.
conjugated antibodies combined with chromogenic sub-
strates are frequently employed for this purpose. However,
some tissues and cells contain endogenous peroxidase,
especially leukocytes and erythrocytes. In cancer tissues,
because of abundant angiogenesis and frequent inﬂamma-
tory inﬁltration, peroxidase-containing cells are common.
This is a major concern when using the highly sensitive
TSA system, the mechanism of which depends on peroxidase
activity and which provides up to 1000-fold ampliﬁcation
in detection sensitivity [13], as endogenous peroxidases
produce signiﬁcant background staining when not inhibited
properly.Becauseofthisconcern,wetesteddiﬀerentquench-
ing methods for endogenous peroxidase. Hydrogen peroxide
is mostly commonly used in immunohistochemistry, at a
typical concentration from 0.3% to 3% diluted in methanol
or PBS buﬀer and an incubation time of 10 to 60 minutes
(lower concentrations require longer incubation times but
mayinducelessdamagetocertainantigensofinterest).Aless
known method was reported by Weir and colleagues decades
ago, that is, to incubate slides with 0.024M hydrochloric
acid (HCl) in ethanol for 10 minutes to eﬃciently destroy
endogenous peroxidase [14]. We compared the use of 3%
H2O2 (Figures 2(a) and 2(b)) and 0.024M HCl (Figures 2(c)
and 2(d)) on consecutive FFPE sections. The diﬀerence is
striking,whereinincubationwiththeHClsolutionproduced
a nearly complete suppression of endogenous peroxidase
whenincubatedonlyfor10minutes,butin3%H2O2-treated
samples at the same incubation time, inﬂammatory cells and
even some carcinoma cells are quite positive with highly
sensitive Cy5-tyramide detection (Figure 2).
Complete suppression of endogenous peroxidase activity
may not be necessary for routine immunohistochemistry as
trace peroxidase will not detectably aﬀect the chromogenic
reaction. However, with the tyramide signal ampliﬁcation
system, trace amounts of active peroxidase can result in
tyramide precipitation, and this high sensitivity dictates the
needs for thorough inhibition of such enzyme activity. As
demonstrated(Figure 2),diluteHClsolutionisaconvenient,
low cost, and highly eﬀective replacement for the tradi-
tional H2O2-blocking step. As for the timing of peroxidase
blocking, we apply this step after section rehydration and
before proteinase K treatment. It should be noted that acid
treatment may also aid hybridization itself.
3.2. Biotin versus Digoxigenin-Labeled Probes. Properly
labeled probes are the most crucial reagent for in situ
hybridization. The ready availability of commercially labeled
oligonucleotide-based probes enables end users to choose
the tracer or reporter that best ﬁts their protocols. Biotin,
digoxigenin, and ﬂuorescein have been frequently used as
reporter molecules on probes.
Early versions of the commercially available TSA system
used streptavidin-biotin aﬃnity for initial signal detection.
In this reaction schema, a biotinylated probe hybridizes
with a single-stranded target sequence, HRP-conjugated
streptavidin binds to the biotin, HRP catalyzes the activation
of tyramide conjugated with ﬂuorescein, and active tyramide
precipitates in the vicinity of HRP molecule. Based on this
protocol, we initially used biotinylated probes for in situ
hybridization. However, exploratory tests conﬁrmed that
this is not appropriate for the type of tissues evaluated, as
oral cancer cells are rich in endogenous biotin (Figure 3).
Indeed endogenous biotin (or a similar streptavidin-binding
activity) has been reported in many types of human tissues.
To circumvent this nonspeciﬁc staining problem, alternative
reporters are required. Digoxigenin (DIG) has been long
proven to be a good option as reporter molecule in nucleic6 Journal of Oncology
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Figure 4: miR-146a expression in oral normal squamous epithelia and squamous carcinoma. Microarrayed normal oral tissue (10 cores)
and oral squamous cell carcinoma (40 cores) were evaluated using the optimized ﬂuorescence in situ hybridization protocol as outlined in
Figure 1. The probe for miR-146a is LNA modiﬁed and labeled with digoxigenin at 5  end. (a, b) Normal oral squamous epithelia. As shown
in (a) and (b), cells at the basal layer (adjacent to the white dashed line) are largely negative for miR-146a, while cells at the intermediate
layer are positive. In oral squamous carcinomas, (c) well-diﬀerentiated tumors, shown here is tissue core B6, often exhibit positive miR-
146a staining while (d) poorly diﬀerentiated tumors, shown is tissue core E8, tend to be negative. Red: Cy5-tyramide showing positive
hybridization signals, blue: DAPI-stained nuclei. Original magniﬁcation 400x.
acid probe design [15–17]. As a heptan, the only natural
source of DIG is digitalis plants, signiﬁcantly reducing the
likelihood that the anti-DIG antibody will bind any endoge-
nous antigens in animal tissues. This provides the advantage
of less nonspeciﬁc background in in situ hybridization.
3.3. LNA Probes Provide Better Speciﬁcity and Sensitivity.
Locked nucleic acid (LNA) is a nucleic acid analog that
contains at least one nucleotide monomer with a bicyclic
furanose ring locked in a conformation mimicking RNA
[18]. This conﬁguration is advantageous as a probe material
for microRNA detection. As the length of microRNA is
only about 22 nucleotides, many microRNA molecules are
diﬀerentiatedfromeachotherbyonlyafewbases,suchthatit
is diﬃcult to achieve appropriate high-level probe sensitivity
and speciﬁcity. The physicochemical properties of LNA
provide an eﬀective solution to this problem. LNA-modiﬁed
oligonucleotides demonstrate much higher thermal stability
and higher melting temperatures when hybridized with
targetRNA sequencescomparedtounmodiﬁed counterparts
[19]. It improves the mismatch discrimination, increasing
the base-pairing selectivity and providing the needed high
degree of aﬃnity for eﬀective microRNA hybridization.
Using a commercially available LNA-modiﬁed DIG-
labeled probe under the conditions outlined above resulted
in appropriate diﬀerential staining (Figure 4). Prickle cells
(stratum spinosum) in most normal oral squamous epithelia
were positive for miR-146a, while basal cells exhibited neg-
ative staining. This kind of good performance is consistentJournal of Oncology 7
with other studies showing the use of LNA-based probes for
hybridization-based microRNA detection [19].
3.4. Tyramide Signal Ampliﬁcation System Provides Enhanced
Sensitivity. The introduction of tyramide conjugates as
substrates for HRP has revolutionized the sensitivity of
any HRP-based detection system [20]. Mechanistically, HRP
reacts with hydrogen peroxide and the phenolic part of
tyramide and produces a quinone-like structure with a
radical on the C2 group, becoming “activated.” Activated
tyramide then rapidly and covalently binds to all nearby
tyrosine residues with proximity to the initially immobilized
HRP site such that signal resolution is not compromised
[21]. Previous studies have shown that the tyramide signal
ampliﬁcation system, which was also known as catalyzed
reporter deposition method (CARD), provides the capability
to identify single copy DNA or RNA with conjugated
ﬂuorophore [21, 22].
To detect microRNA insituwithprobe-basedapproaches
requires such highly sensitive signal ampliﬁcation. We have
tested the use of the more traditional chromogenic substrate
diaminobenzidine (DAB) with HRP-labeled anti-DIG anti-
body in the context of LNA-based DIG-labeled probes but
did not get well-diﬀerentiated staining in in situ hybridiza-
tion. The use of TSA eliminated this diﬃculty. The caveat is
that when using any TSA system, complete suppression of
endogenous peroxidase is essential, as discussed above.
Another well-recognized way of amplifying positive sig-
nal from nucleic acid hybridization is branched DNA signal
ampliﬁcation [23, 24], which makes use of multiple layers of
probes with the last layer being extensively enzyme labeled.
However, for microRNA detection, the primary probes still
require the LNA or LNA-like nucleotides to enhance the
initial speciﬁcity and sensitivity, and signal ampliﬁcation
with the branched DNA procedure is less customizable than
the TSA system allows. The use of branched DNA signal
ampliﬁcation for in situ hybridization microRNA detection
has not been reported.
4. Conclusion
FFPE tissues initially appeared to be a challenging platform
for microRNA detection but are actually better suited for
microRNA than mRNA studies as recently revealed [10, 11,
25]. Thus, clinically archived cancer tissue specimens can
represent buried treasure, as microRNAs are well preserved
in such materials. Our study has demonstrated that after
eﬃcient inhibition of endogenous peroxidase, LNA-based
and digoxigenin-labeled probe, applied together with tyra-
mide signal ampliﬁcation, signiﬁcantly improves the results
ofﬂuorescenceinsituhybridizationformicroRNAdetection.
In summary, we have established a feasible in situ
hybridization procedure for detecting the expression of
microRNA in FFPE oral cancer tissues. This detection is
important for studies on the participation of microRNA in
oral cancer pathology and may have potential prognostic or
diagnostic value as large cohort studies using such material
will conﬁrm.
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